• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同心力衰竭类型的健康相关生活质量:与临床特征及预后的关联

Health-related quality of life across heart failure categories: associations with clinical characteristics and outcomes.

作者信息

Settergren Camilla, Benson Lina, Dahlström Ulf, Thorvaldsen Tonje, Savarese Gianluigi, Lund Lars H, Shahim Bahira

机构信息

Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.

Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.

出版信息

ESC Heart Fail. 2025 Jun;12(3):1977-1991. doi: 10.1002/ehf2.15206. Epub 2025 Jan 27.

DOI:10.1002/ehf2.15206
PMID:39871494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12055387/
Abstract

AIMS

The study aims to examine characteristics and outcomes associated with health-related quality of life (HRQoL) in patients with heart failure (HF) with preserved, mildly reduced and reduced ejection fraction (EF) (HFpEF, HFmrEF and HFrEF).

METHODS AND RESULTS

Data on HRQoL were collected in the Swedish Heart Failure Registry (SwedeHF; 2000-2021) using the EuroQoL 5-dimensional visual analogue scale (EQ 5D-vas). Baseline EQ 5D-vas scores were categorized as 'best' (76-100), 'good' (51-75), 'bad' (26-50) and 'worst' (0-25). Independent associations between patients' characteristics and EQ 5D-vas, as well as between EQ 5D-vas and outcomes were assessed. Of 40 809 patients (median age 74 years; 32% female), 29% were in the 'best', 41% in the 'good', 25% in the 'bad' and 5% in the 'worst' EQ 5D-vas categories, similarly distributed across all EF categories. Higher New York Heart Association (NYHA) class was strongly associated with lower EQ 5D-vas regardless of EF categories, followed by chronic obstructive pulmonary disease, smoking, body mass index, higher heart rate, anaemia, previous stroke, ischaemic heart disease, use of diuretics and living alone, whereas higher income, male sex, outpatient status and higher systolic blood pressure were inversely associated with lower EQ 5D-vas categories. Patients in the 'worst' EQ 5D-vas category as compared with the 'best' had the highest risk of all-cause death [adjusted hazard ratios 1.97, 95% confidence interval (CI) 1.64-2.37 in HFrEF, 1.77, 95% CI 1.30-2.40 in HFmrEF and 1.43 95% CI 1.02-2.00 in HFpEF].

CONCLUSIONS

Most patients were in the two highest EQ 5D-vas categories. Higher NYHA class had the strongest association with lower EQ 5D-vas categories, across all EF categories. Patients in the worst EQ 5D-vas category were at the highest risk of mortality.

摘要

目的

本研究旨在探讨射血分数保留、轻度降低和降低的心力衰竭(HF)患者(HFpEF、HFmrEF和HFrEF)与健康相关生活质量(HRQoL)相关的特征和结局。

方法和结果

使用欧洲五维视觉模拟量表(EQ 5D-vas)在瑞典心力衰竭登记处(SwedeHF;2000-2021年)收集HRQoL数据。基线EQ 5D-vas评分分为“最佳”(76-100)、“良好”(51-75)、“较差”(26-50)和“最差”(0-25)。评估患者特征与EQ 5D-vas之间以及EQ 5D-vas与结局之间的独立关联。在40809例患者(中位年龄74岁;32%为女性)中,29%处于EQ 5D-vas“最佳”类别,41%处于“良好”类别,25%处于“较差”类别,5%处于“最差”类别,在所有射血分数类别中分布相似。无论射血分数类别如何,纽约心脏协会(NYHA)分级越高与EQ 5D-vas越低密切相关,其次是慢性阻塞性肺疾病、吸烟、体重指数、心率加快、贫血、既往中风、缺血性心脏病、使用利尿剂和独居,而较高收入、男性、门诊状态和较高收缩压与较低EQ 5D-vas类别呈负相关。与“最佳”类别相比,处于EQ 5D-vas“最差”类别的患者全因死亡风险最高[HFrEF患者调整后风险比为1.97,95%置信区间(CI)为1.64-2.37;HFmrEF患者为1.77,95%CI为1.30-2.40;HFpEF患者为1.43,95%CI为1.02-2.00]。

结论

大多数患者处于EQ 5D-vas的两个最高类别。在所有射血分数类别中,较高的NYHA分级与较低的EQ 5D-vas类别关联最强。处于EQ 5D-vas最差类别的患者死亡风险最高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c34a/12055387/1d4dd1961e05/EHF2-12-1977-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c34a/12055387/e57705cbbfd5/EHF2-12-1977-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c34a/12055387/fd0718338166/EHF2-12-1977-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c34a/12055387/71446cf8d492/EHF2-12-1977-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c34a/12055387/1d4dd1961e05/EHF2-12-1977-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c34a/12055387/e57705cbbfd5/EHF2-12-1977-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c34a/12055387/fd0718338166/EHF2-12-1977-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c34a/12055387/71446cf8d492/EHF2-12-1977-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c34a/12055387/1d4dd1961e05/EHF2-12-1977-g003.jpg

相似文献

1
Health-related quality of life across heart failure categories: associations with clinical characteristics and outcomes.不同心力衰竭类型的健康相关生活质量:与临床特征及预后的关联
ESC Heart Fail. 2025 Jun;12(3):1977-1991. doi: 10.1002/ehf2.15206. Epub 2025 Jan 27.
2
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.达格列净对射血分数降低和轻度降低/保留的心力衰竭患者生活质量的影响,采用欧洲五维健康量表问卷进行评估。
Eur J Heart Fail. 2024 Jul;26(7):1524-1538. doi: 10.1002/ejhf.3263. Epub 2024 May 3.
3
Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum.贫血在射血分数谱心力衰竭中的患病率、相关性及其预后作用。
Int J Cardiol. 2020 Jan 1;298:59-65. doi: 10.1016/j.ijcard.2019.08.049. Epub 2019 Aug 28.
4
Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.心力衰竭中纵向射血分数变化的流行率和预后意义。
JACC Heart Fail. 2019 Apr;7(4):306-317. doi: 10.1016/j.jchf.2018.11.019. Epub 2019 Mar 6.
5
Cause-specific death in heart failure across the ejection fraction spectrum: A comprehensive assessment of over 100 000 patients in the Swedish Heart Failure Registry.射血分数谱心力衰竭的病因特异性死亡:瑞典心力衰竭注册研究中超过 100000 例患者的综合评估。
Eur J Heart Fail. 2024 May;26(5):1150-1159. doi: 10.1002/ejhf.3230. Epub 2024 Apr 12.
6
A comprehensive population-based characterization of heart failure with mid-range ejection fraction.具有中等范围射血分数的心力衰竭的综合人群特征描述。
Eur J Heart Fail. 2017 Dec;19(12):1624-1634. doi: 10.1002/ejhf.945. Epub 2017 Sep 25.
7
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.慢性心力衰竭伴射血分数保留、中间范围和降低患者的流行病学和一年结局:ESC 心力衰竭长期注册研究分析。
Eur J Heart Fail. 2017 Dec;19(12):1574-1585. doi: 10.1002/ejhf.813. Epub 2017 Apr 6.
8
Assessing the diversity and determinants of health-related quality of life measures in patients with acute heart failure.评估急性心力衰竭患者健康相关生活质量测量的多样性和决定因素。
ESC Heart Fail. 2024 Aug;11(4):1963-1970. doi: 10.1002/ehf2.14745. Epub 2024 Mar 20.
9
Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.射血分数保留、中间范围和降低的心衰伴发的心房颤动。
JACC Heart Fail. 2017 Aug;5(8):565-574. doi: 10.1016/j.jchf.2017.05.001. Epub 2017 Jul 12.
10
Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study.射血分数保留、中等范围和降低的心力衰竭患者中缺血性心脏病的意义:一项全国性队列研究
Circ Heart Fail. 2017 Jun;10(6). doi: 10.1161/CIRCHEARTFAILURE.117.003875.

本文引用的文献

1
Heart failure with preserved ejection fraction.射血分数保留的心力衰竭。
Nat Rev Dis Primers. 2024 Aug 14;10(1):55. doi: 10.1038/s41572-024-00540-y.
2
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.达格列净对射血分数降低和轻度降低/保留的心力衰竭患者生活质量的影响,采用欧洲五维健康量表问卷进行评估。
Eur J Heart Fail. 2024 Jul;26(7):1524-1538. doi: 10.1002/ejhf.3263. Epub 2024 May 3.
3
Logistic regression vs. predictive mean matching for imputing binary covariates.
Logistic 回归与预测均值匹配在二进制协变量插补中的比较。
Stat Methods Med Res. 2023 Nov;32(11):2172-2183. doi: 10.1177/09622802231198795. Epub 2023 Sep 26.
4
Changing health related quality of life and outcomes in heart failure by age, sex and subtype.心力衰竭患者健康相关生活质量及预后随年龄、性别和亚型的变化情况
EClinicalMedicine. 2023 Sep 14;64:102217. doi: 10.1016/j.eclinm.2023.102217. eCollection 2023 Oct.
5
Association Between Disease-specific Health-related Quality of Life and All-cause Mortality in Patients with Heart Failure: A Meta-analysis.疾病特异性健康相关生活质量与心力衰竭患者全因死亡率的关系:一项荟萃分析。
Curr Probl Cardiol. 2023 Apr;48(4):101592. doi: 10.1016/j.cpcardiol.2023.101592. Epub 2023 Jan 8.
6
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.2021年欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗指南:由欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗特别工作组制定,并得到欧洲心脏病学会心力衰竭协会(HFA)的特别贡献。
Rev Esp Cardiol (Engl Ed). 2022 Jun;75(6):523. doi: 10.1016/j.rec.2022.05.005.
7
Factors associated with health-related quality of life in heart failure in 23 000 patients from 40 countries: results of the G-CHF research programme.40 个国家 23000 例心力衰竭患者健康相关生活质量的相关因素:G-CHF 研究项目的结果。
Eur J Heart Fail. 2022 Sep;24(9):1478-1490. doi: 10.1002/ejhf.2535. Epub 2022 Jun 15.
8
Quality of life assessed 6 months after hospitalisation for acute heart failure: an analysis from REPORT-HF (international REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure).急性心力衰竭住院 6 个月后的生活质量评估:来自 REPORT-HF(国际心力衰竭治疗纵向观察评估医疗实践注册研究)的分析。
Eur J Heart Fail. 2022 Jun;24(6):1020-1029. doi: 10.1002/ejhf.2508. Epub 2022 May 12.
9
Heart failure with mid-range or mildly reduced ejection fraction.射血分数中间值或轻度降低的心力衰竭。
Nat Rev Cardiol. 2022 Feb;19(2):100-116. doi: 10.1038/s41569-021-00605-5. Epub 2021 Sep 6.
10
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.